Baker Bros. Advisors »

Parabilis Medicines shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Parabilis Medicines shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Parabilis Medicines

Tip: Access up to 7 years of quarterly data

All positions including Parabilis Medicines held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Parabilis Medicines by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $14M 500k 27.37

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeOne Medicines Sponsored Ads (ONC)
Revolution Medicines (RVMD)
Madrigal Pharmaceuticals (MDGL)
ACADIA Pharmaceuticals (ACAD)
Kymera Therapeutics (KYMR)
Insmed Incorporated Com Par $.01 (INSM)
Celcuity (CELC)
Kodiak Sciences (KOD)
Rhythm Pharmaceuticals (RYTM)
Praxis Precision Medicines I (PRAX)
Alkermes SHS (ALKS)
Summit Therapeutics (SMMT)
Grail (GRAL)
Abcellera Biologics (ABCL)

View all positions for Baker Bros. Advisors

Top funds holding Parabilis Medicines

RA Capital Management
Arch Venture Corp
venBio Partners
Nextech Invest
Regeneron Pharmaceuticals
Jupiter Topco
Soleus Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
Jpmorgan Chase & Co
Alliancebernstein
VR Adviser
Samsara BioCapital
Baker Bros. Advisors
Marshall Wace

View all funds holding Parabilis Medicines